New cancer drug combo enters first human tests
Disease control
Recruiting now
This early-stage trial tests a new oral drug, FX-909, alone or with pembrolizumab, in people with advanced solid tumors like bladder cancer. The main goals are to check safety and find the right dose. About 120 adults will take the drug daily and have regular scans and blood test…
Phase: PHASE1 • Sponsor: Flare Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 11:51 UTC